Avalyn Pharma Inc. · NASDAQ:AVLN
Montanova Capital, LLC reported a 5.60% stake in Avalyn Pharma Inc. (Schedule 13D)
Event May 1, 2026 · Filed May 8, 2026
Montanova Capital, LLC reported a 5.60% stake in Avalyn Pharma Inc., 2,503,109 shares, with active intent on May 1, 2026. Filed May 8, 2026 (Schedule 13D).
- Stake
- 5.60%
- Shares
- 2,503,109
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.60% | 2,503,109 |
| Averill Master Fund, Ltd. | 4.90% | 2,179,283 |
| Averill Madison Master Fund, Ltd. | 0.70% | 323,826 |
| Aaron Cowen | 5.60% | 2,503,109 |
Source
Related
- Avalyn Pharma Inc.
- Montanova Capital, LLC
- Avalyn Pharma Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Norwest Venture Partners XV, LP · Aug 11, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D · SR One Capital Management, LLC · May 8, 2026
- Schedule 13G · Perceptive Advisors LLC · May 7, 2026